These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 79880)

  • 1. Dare we count the cost of cancer chemotherapy?
    Berry RJ; Bryan G
    Lancet; 1978 Sep; 2(8088):516-8. PubMed ID: 79880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of health care services in the treatment of cancer.
    Ilbery PL
    Aust Fam Physician; 1978 Aug; 7(8):1062-74. PubMed ID: 101189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economics of providing antineoplastic drugs in a manufacturer-mixed bulk package.
    Kleinberg ML; Duafala ME
    Am J Hosp Pharm; 1988 Jan; 45(1):109-15. PubMed ID: 3348222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in chemotherapy for large cell lymphoma.
    Coleman M; Gerstein G; Topilow A; Lebowicz J; Berhardt B; Chiarieri D; Silver RT; Pasmantier MW
    Semin Hematol; 1987 Apr; 24(2 Suppl 1):8-20. PubMed ID: 2438781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost considerations in cancer chemotherapy.
    Tattersall MH; Friedlander ML
    Aust Health Rev; 1982 May; 5(2):21-4. PubMed ID: 10309735
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical pharmacology of anticancer drugs.
    Chabner BA; Myers CE; Oliverio VT
    Semin Oncol; 1977 Jun; 4(2):165-91. PubMed ID: 69319
    [No Abstract]   [Full Text] [Related]  

  • 7. Second cancer incidence in primary mediastinal B-cell lymphoma treated with methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin regimen with or without rituximab and mediastinal radiotherapy: Results from a monoinstitutional cohort analysis of long-term survivors.
    De Sanctis V; Alfò M; Di Rocco A; Ansuinelli M; Russo E; Osti MF; Valeriani M; Minniti G; Grapulin L; Musio D; Bracci S; Spagnoli A; Moleti ML; Tombolini V; Martelli M
    Hematol Oncol; 2017 Dec; 35(4):554-560. PubMed ID: 28078727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining drug dispensing costs for use in cost-accounting systems.
    Thielke TS; Charlson JT; Heckethorn D
    Am J Hosp Pharm; 1988 Apr; 45(4):844-7. PubMed ID: 3376969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost of operating a computer-assisted unit-dose drug distribution system.
    Schnell BR; Anderson HA; Walter DE; Kessler LD; Buckley AL
    Can J Hosp Pharm; 1975; 28(5):149-53. PubMed ID: 10236913
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect on drug costs of implementing decentralized drug distribution.
    Roberts AW
    Am J Hosp Pharm; 1983 Apr; 40(4):604-6. PubMed ID: 6846367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of drug distribution costs for controlled versus noncontrolled oral analgesics.
    Reynolds RC; Ploetz P; Thielke TS
    Am J Hosp Pharm; 1984 Aug; 41(8):1558-63. PubMed ID: 6475974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ineffectiveness of high-dosage methotrexate in patients with small cell bronchial cancer].
    Sauer H; Drings P; Schalhorn A; Wilmanns W
    Onkologie; 1982 Aug; 5(4):174-7. PubMed ID: 6292806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
    Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
    J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost analysis of a satellite pharmacy.
    Kelly WN; Meyer JD; Flatley CJ
    Am J Hosp Pharm; 1986 Aug; 43(8):1927-30. PubMed ID: 3092647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are oncology nurses too expensive?
    Mortenson LE
    Oncol Nurs Forum; 1984; 11(1):14-5. PubMed ID: 6558680
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recent personal results in advanced bronchial cancer. Palliative immuno-chemotherapy. 63 cases].
    Israel L; Depierre A
    Ann Med Interne (Paris); 1976 Jan; 127(1):39-42. PubMed ID: 64125
    [No Abstract]   [Full Text] [Related]  

  • 17. Sequential combination chemotherapy for advanced squamous cell carcinoma of the head and neck.
    Lester EP; Kinnealey A; Matz GJ
    Laryngoscope; 1979 Dec; 89(12):1921-9. PubMed ID: 92740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Economic bases of treatment intensification at specialized oncological facilities].
    Diatchenko OT; Shabashova NIa; Antashkova NN; Zamiatina NA; Pirkovskaia TI; Kogalenko VIa
    Vopr Onkol; 1990; 36(1):46-51. PubMed ID: 2305562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escalating costs for cancer chemotherapy.
    Nyman JV; Dorr RT; Hall GR
    Am J Hosp Pharm; 1981 Aug; 38(8):1151-4. PubMed ID: 7270558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost efficiency, factor interchange, and technical progress in US specialized hospital pharmacies.
    Okunade AA; Suraratdecha C
    Health Econ; 1998 Jun; 7(4):363-71. PubMed ID: 9683096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.